Learn more

PROTIA LLC

Overview
  • Total Patents
    269
  • GoodIP Patent Rank
    212,907
About

PROTIA LLC has a total of 269 patent applications. Its first patent ever was published in 2007. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and African Regional Industrial Property Organization. Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and foods and drinks are MYCOVIA PHARMACEUTICALS INC, CZARNIK ANTHONY W and GLACEUM INC.

Patent filings per year

Chart showing PROTIA LLCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Czarnik Anthony W 246
#2 Czarnik Anthony 21
#3 Mckinney Jeffrey 12
#4 Mckinney Jeffrey A 1
#5 Anthony Czarnik 1
#6 Jeffrey Mckinney 1

Latest patents

Publication Filing date Title
US2011160270A1 Deuterium-enriched sdx-101
US2009082383A1 Deuterium-enriched buprenorphine
US2009082387A1 Deuterium-enriched nvp-bez234
US2009082432A1 Deuterium-enriched ramelteon
US2009082469A1 Deuterium-enriched terbinafine
US2009082436A1 Deuterium-enriched rivastigmine
US2009082363A1 Deuterium-enriched posaconazole
US2009082385A1 Deuterium-enriched desloratidine
US2009088416A1 Deuterium-enriched lapaquistat
US2009082306A1 Deuterium-enriched telbivudine
US2009082335A1 Deuterium-enriched oxcarbazepine
US2009082468A1 Deuterium-enriched levalbuterol
US2009082452A1 Deuterium-enriched lumiracoxib
US2009082422A1 Deuterium-enriched levetiracetam
US2009082442A1 Deuterium-enriched lubiprostone
US2009082414A1 Deuterium-enriched viramidine
US2009082366A1 Deuterium-enriched telaprevir
US2009082318A1 Deuterium-enriched mometasone
US2009082364A1 Deuterium-enriched levocedtirizine
US2009082361A1 Deuterium-enriched imatinib